Taysha Gene Therapies shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $29k | 16k | 1.77 |
| 2023-09-30 | $51k | 16k | 3.16 |
| 2023-06-30 | $11k | 16k | 0.66 |
| 2023-03-31 | $13k | 16k | 0.80 |
| 2022-12-31 | $37k | 16k | 2.26 |
| 2022-09-30 | $32k | 16k | 1.98 |
| 2022-06-30 | $338k | 91k | 3.73 |
| 2022-03-31 | $1.1M | 165k | 6.53 |
| 2021-12-31 | $1.9M | 163k | 11.65 |
| 2021-09-30 | $2.9M | 158k | 18.62 |
| 2021-06-30 | $1.8M | 87k | 21.21 |
| 2021-03-31 | $1.2M | 58k | 20.31 |
| 2020-12-31 | $1.4M | 52k | 26.55 |
More positions owned by Charles Schwab Investment Management
Home Depot (HD)
View all positions for Charles Schwab Investment Management